EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

A Severe Case of Drug-Induced Liver Injury after Gemcitabine Administration: A Highly Probable Causality Grading as Assessed by the Updated RUCAM Diagnostic Scoring System

Ilenia Mascherona iD, Caterina Maggioli, Maira Biggiogero, Oreste Mora, Lucia Marelli

Case Reports in Hepatology · 01.10.2020 · 2020 · 1-5

DOI: 10.1155/2020/8812983 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Hepatology, erschienen am 01.10.2020. Verfasst von Ilenia Mascherona und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ospedale La Carità, Medicina Interna, Locarno, Switzerland. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gemcitabine is an antineoplastic drug used in several forms of advanced pancreatic, lung, breast, ovarian, and bladder cancer. Common side effects include bone marrow suppression, fatigue, diarrhea, nausea, gastrointestinal upset, rash, alopecia, and stomatitis. Transient serum enzyme elevations could be observed during therapy, but clinically significant acute liver injury has been rarely associated with its use. Few cases of acute liver injury have been reported in the literature. We reported the clinical case of a 73--year-old man who developed clinically significant acute hepatic injury after using gemcitabine. Possible causes, clinical presentation, and treatments are discussed. According to the updated RUCAM score, the case was rated 10 points and became a suspected drug-induced liver injury. Moreover, on the liver biopsy, there were histological findings of mild-to-moderate portal hepatitis, eosinophilia, bile duct injury, and mild perisinusoidal fibrosis, suggesting drug damage.

Autor:innen und Institutionen

  • Ospedale La Carità, Medicina Interna, Locarno, Switzerland.
  • AUSL di Bologna, Ospedale di Budrio, Bologna, Italy.
  • Clinica Luganese Moncucco, Unità di Ricerca Clinica, Lugano, Switzerland.
  • Clinica Luganese Moncucco, Oncologia Medica, Lugano, Switzerland.

ORCID-Profile: Ilenia Mascherona

Zitieren

APA

Mascherona, I., Maggioli, C., Biggiogero, M., Mora, O., & Marelli, L. (2020). A Severe Case of Drug-Induced Liver Injury after Gemcitabine Administration: A Highly Probable Causality Grading as Assessed by the Updated RUCAM Diagnostic Scoring System. Case Reports in Hepatology, 2020, 1-5. https://doi.org/10.1155/2020/8812983

Vancouver

Mascherona I, Maggioli C, Biggiogero M, Mora O, Marelli L. A Severe Case of Drug-Induced Liver Injury after Gemcitabine Administration: A Highly Probable Causality Grading as Assessed by the Updated RUCAM Diagnostic Scoring System. Case Reports in Hepatology. 2020;2020:1-5. doi:10.1155/2020/8812983

BibTeX
@article{Mascherona2020,
  author = {Mascherona, Ilenia and Maggioli, Caterina and Biggiogero, Maira and Mora, Oreste and Marelli, Lucia},
  title = {A Severe Case of Drug-Induced Liver Injury after Gemcitabine Administration: A Highly Probable Causality Grading as Assessed by the Updated RUCAM Diagnostic Scoring System},
  journal = {Case Reports in Hepatology},
  year = {2020},
  volume = {2020},
  pages = {1--5},
  doi = {10.1155/2020/8812983}
}
Kostenlos starten →